Archives: Contractor Email

Dear Contractor

The Public Health Agency has oversight of the COVID-19 Vaccination programme in Northern Ireland and has requested that SPPG provide sufficient information to assure that all 477 RQIA registered Care Homes are paired with respective CPVS pharmacies to achieve the successful completion of the Spring COVID-19 Booster Campaign by end of May 2022.

The recent Update G12 outlined the request for the network of Moderna CPVS pharmacies to complete an e-form for each care home requiring to be vaccinated, on a weekly basis each Wednesday.

This is a REMINDER to submit an individual e-form for all of the Care Homes you have made arrangements with, to deliver vaccination clinics. Please complete e-form submissions TODAY.

From 21 April 2022, SPPG would ask that you complete the e-form as soon as you have made a pairing arrangement with a Care Home.

Please do not hesitate to contact CPNI should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
Please find correspondence HERE from Kathryn Turner, Pharmacy Lead, Strategic Planning and Performance Group.

SUMMARY

  • Evaluations for the last campaign, “Making Healthier Choices”, can now be submitted. This survey is available from 4 April 2022 and should have been completed by 2 May 2022. It can be accessed at HERE.
  • It is vital that all pharmacies contracted to provide “Living Well” submit their evaluation survey after each campaign as it allows data to be collated to demonstrate the value and impact of the service to other sectors.
  • Compliance will be monitored with the service requirements, in particular evaluation submission. Where failure has been identified to comply, such as failure to submit evaluation data, the right to recover all, or part of, this funding via an adjustment to the pharmacy’s BSO payment account is reserved.

ACTION

  • Contractors are asked to review the correspondence.
  • Submit evaluations for the last campaign, “Making Healthier Choices” as soon as possible. It can be accessed at HERE.
  • Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.

BSO ALERTS 

CPNI ALERTS 

DOH(NI) ALERTS 

Please bring this to the attention of your pharmacy team(s).
Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via the CPNI’s Medicine Shortage Reporter and Situation Reporter.

Kind regards

SENT ON BEHALF OF 
DR. GARETH C. GILVARY
Governance & Support Pharmacist
Dear Colleague
The final update of concessionary prices were granted for April 2022:
DrugPack SizeConcessionary Price
Bimatoprost 100micrograms/ml eye drops3£3.10
Celecoxib 100mg capsules60£7.22
Clonidine 25microgram tablets112£11.52
Dipyridamole 100mg tablets84£21.89
Exemestane 25mg tablets30£3.40
Fluoxetine 40mg capsules30£3.40
Lercanidipine 10mg tablets28£4.24
Losartan 100mg / Hydrochlorothiazide 25mg tablets28£11.66
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets28£5.62
Mometasone 0.1% cream100£10.94
Mometasone 0.1% cream30£3.28
Moxonidine 200microgram tablets28£6.63
Prasugrel 10mg tablets28£12.97
Rizatriptan 10mg tablets3£3.63
Solifenacin 5mg tablets30£3.54
Solifenacin 10mg tablets30£4.01
Sulfasalazine 500mg gastro-resistant tablets112£39.93
Sulfasalazine 500mg tablets112£33.96
Trimethoprim 50mg/5ml oral suspension sugar free100£9.48

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
DR. GARETH C. GILVARY
Governance & Support Pharmacist
Dear Colleague
The third update of concessionary prices were granted for April 2022:
DrugPack SizeConcessionary Price
Co-codamol 30mg/500mg effervescent tablets32£2.03
Co-codamol 30mg/500mg effervescent tablets100£6.34
Co-tenidone 100mg/25mg tablets28£1.42
Ibandronic Acid 50mg tablets28£145.99
Isotretinoin 20mg capsules30£16.02
Sulfasalazine 250mg/5ml oral suspension sugar free500£94.22
Tamoxifen 10mg/5ml oral solution sugar free150£74.52
Valsartan 160mg capsules28£7.08

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
DR. GARETH C. GILVARY
Governance & Support Pharmacist
Dear Colleague
Please find correspondence HERE from SPPG Pharmacy and Medicines Management team.

SUMMARY

  • The updated Pharmacy Collect poster has been redesigned. This version will be shared with community pharmacies when printed.
  • The e-form by which contractors submit the number of transactions to BSO will be amended in line with the updated Pharmacy Collect service specification. This will take effect from Tuesday 3 May 2022.
  • Contractors are reminded that submission of this data is used to populate the payment claim. It is also used for monitoring, reporting and service evaluation purposes.

ACTION

  • Contractors are asked to review the correspondence.
  • If you have any queries in relation to the changes outlined in this email please contact your local Integrated Care Office.
  • Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive